Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
233.1 USD | +1.43% | +6.23% | -10.21% |
May. 31 | Biogen: Brussels grants marketing authorization for Charcot disease | CF |
May. 31 | Disaster averted |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.21% | 33.46B | |
-1.62% | 90.85B | |
-0.92% | 39.02B | |
-18.63% | 14.51B | |
-6.08% | 13.22B | |
-9.76% | 11.65B | |
-47.31% | 10.57B | |
+6.52% | 9.23B | |
+137.06% | 7.71B | |
-4.76% | 7.22B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- AbCellera, Biogen Collaborate to Discover Treatments for Neurological Diseases